Mauro Pettorruso
Overview
Explore the profile of Mauro Pettorruso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertoli M, Zappasodi F, Croce P, De Iure D, Pettorruso M, Cavallotto C, et al.
J Affect Disord
. 2025 Mar;
379:58-71.
PMID: 40058466
Background: Cognitive inhibition is key to cognitive control in healthy and psychiatric conditions. Bipolar Disorder (BD) individuals display a range of inhibitory deficits and high levels of impulsivity across all...
2.
Chiappini S, Sampogna G, Ventriglio A, Menculini G, Ricci V, Pettorruso M, et al.
Expert Rev Neurother
. 2025 Feb;
:1-21.
PMID: 40013928
Introduction: The phenomenology of depression is characterized by a wide array of emotional, cognitive, and physical symptoms that significantly disrupt an individual's life. Societal changes, driven by technological advancements, economic...
3.
Mosca A, Chiappini S, Mancusi G, Miuli A, Marrangone C, Allegretti R, et al.
Curr Neuropharmacol
. 2025 Feb;
PMID: 39976040
Background: The widespread availability and accessibility of over-the-counter (OTC) medicines play a vital role in modern healthcare systems, enabling individuals to manage minor health concerns independently. However, certain OTC medications...
4.
Rosso G, dAndrea G, Barlati S, Di Nicola M, Andriola I, Marcatili M, et al.
Curr Neuropharmacol
. 2025 Jan;
23(5):e1570159X337670.
PMID: 39810448
Introduction/objective: Data on long-term treatment with Esketamine Nasal Spray (ESKNS) in real-world patients with treatment resistant depression (TRD) is scarce. The primary aim of the study is to evaluate the...
5.
Guidotti R, Basti A, Pieramico G, DAndrea A, Makkinayeri S, Pettorruso M, et al.
J Neural Eng
. 2024 Dec;
22(1).
PMID: 39622179
The brain is a highly complex physical system made of assemblies of neurons that work together to accomplish elaborate tasks such as motor control, memory and perception. How these parts...
6.
Pettorruso M, Di Carlo F, Di Lorenzo G, Martinotti G
Addict Behav
. 2024 Nov;
160:108190.
PMID: 39490316
No abstract available.
7.
Montemitro C, Mosca A, Chiappini S, Miuli A, Schifano F, Montano M, et al.
Pharmaceuticals (Basel)
. 2024 Oct;
17(10).
PMID: 39459026
Background: illegal drugs significantly contribute to global health issues, with health complications often occurring not only in regular users with Substance Use Disorders (SUDs) but also in first-time and occasional...
8.
Santorelli M, Miuli A, Pettorruso M, Di Carlo F, de Berardis D, Sensi S, et al.
Curr Neuropharmacol
. 2024 Oct;
PMID: 39449332
Background: Co-occurrence of substance use disorders is frequent in patients with mental health disorders is a condition known as "dual diagnosis". The use of substances worsens the prognosis and lowers...
9.
dAndrea G, De Risio L, Di Lorenzo G, Zoratto F, Pompili E, Nicolo G, et al.
J Affect Disord
. 2024 Sep;
369:146-148.
PMID: 39341287
No abstract available.
10.
DOnofrio A, Balzoni L, Ferrajoli G, Di Vincenzo F, Napolitano D, Schiavoni E, et al.
Minerva Gastroenterol (Torino)
. 2024 Sep;
PMID: 39292181
Background: Biological agents were found to alter the psychopathological profile of a small subgroup of patients treated for a variety of conditions, including inflammatory bowel disease (IBD) and psychiatric disorders....